Publications

Detailed Information

신생병원의 5년 유방암 치료 경험: 임상 데이터 웨어하우스를 이용한 분석 : Five-years of Breast Cancer Management in a New Hospital: Analysis Using Clinical Data Warehouse

DC Field Value Language
dc.contributor.author강은영-
dc.contributor.author한상아-
dc.contributor.author김새리-
dc.contributor.author김선미-
dc.contributor.author장미정-
dc.contributor.author이희은-
dc.contributor.author박소연-
dc.contributor.author임재영-
dc.contributor.author양은주-
dc.contributor.author김인아-
dc.contributor.author김유경-
dc.contributor.author허찬영-
dc.contributor.author김유정-
dc.contributor.author김지현-
dc.contributor.author김정현-
dc.contributor.author김성원-
dc.date.accessioned2012-06-29T06:14:37Z-
dc.date.available2012-06-29T06:14:37Z-
dc.date.issued2010-03-
dc.identifier.citationJOURNAL OF BREAST CANCER; Vol.13 1; 96-103ko_KR
dc.identifier.issn1738-6756-
dc.identifier.urihttps://hdl.handle.net/10371/77956-
dc.description.abstractPurpose This study is to review the initial 5-years of breast cancer management in a single hospital using the clinical data warehouse (CDW) Methods: We reviewed the electronic medical records of 754 patients with breast cancer who were treated by a single surgeon between June 2003 and December 2007 in Seoul National University Bundang Hospital We analyzed the epidemiological, clinical and therapeutic profiles of the breast cancer patients which were encoded and stored at the CDW Results: The mean age of the patients was 49.3 years and the peak incidence was in the fifth decade (36.6%) Symptomatic breast cancer was 74.6% and screening-detected breast cancer was 25.4%. Breast conserving surgery (BCS) was performed in 54 1% of all cases and the BCS rate increased annually Immediate reconstruction after mastectomy was performed in 62 cases (17.7%). Sentinel lymph node (SLN) biopsy for nodal staging was performed in 501 cases (72 1%) and 160 cases (23 0%) underwent complete axillary lymph node dissection The proportion of in situ and early stage invasive breast cancer was 85.0%. Six hundred and ninety three patients (92.5%) received more than one adjuvant therapy Thirty one patients experienced local or systemic relapse after surgery and ipsilateral breast tumor recurrence (IBTR) occurred in 6 cases. The median follow-up penod was 29.5 months Two-year and 3-year disease-free survival rates were 95 9% and 94.4% Conclusion. BCS and SLN biopsy continuously increased and immediate reconstruction after mastectomy was performed widely. Most patients received more than one adjuvant therapy. Moreover, we saved the time and human power to review the medical record by using the CDWko_KR
dc.language.isokoko_KR
dc.publisherKOREAN BREAST CANCER SOCko_KR
dc.subjectBreast neoplasmko_KR
dc.subjectComputerized medical records systemsko_KR
dc.subject유방암ko_KR
dc.subject임상 데이터 웨어하우스ko_KR
dc.title신생병원의 5년 유방암 치료 경험: 임상 데이터 웨어하우스를 이용한 분석ko_KR
dc.title.alternativeFive-years of Breast Cancer Management in a New Hospital: Analysis Using Clinical Data Warehouseko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthorKang, Eunyoung-
dc.contributor.AlternativeAuthorHan, Sang Ah-
dc.contributor.AlternativeAuthorKim, Sairhee-
dc.contributor.AlternativeAuthorKim, Sun Mi-
dc.contributor.AlternativeAuthorLee, Hee Eun-
dc.contributor.AlternativeAuthorLim, Jae-Young-
dc.contributor.AlternativeAuthorKim, In Ah-
dc.contributor.AlternativeAuthorHeo, Chan Yeong-
dc.contributor.AlternativeAuthorKim, Jee-Hyun-
dc.contributor.AlternativeAuthorKim, Sung-Won-
dc.contributor.AlternativeAuthorKim, Jeong-Hyun-
dc.contributor.AlternativeAuthorKim, Yu Jung-
dc.contributor.AlternativeAuthorKim, Yu Kyeong-
dc.contributor.AlternativeAuthorYang, Eun Joo-
dc.contributor.AlternativeAuthorPark, So Yeon-
dc.contributor.AlternativeAuthorJang, Mijung-
dc.identifier.doi10.4048/jbc.2010.13.1.96-
dc.citation.journaltitleJOURNAL OF BREAST CANCER-
dc.description.citedreferenceRastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235-
dc.description.citedreferenceAhn SH, 2006, BREAST CANCER RES TR, V99, P209, DOI 10.1007/s10549-006-9188-x-
dc.description.citedreferenceSon BH, 2006, ARCH SURG-CHICAGO, V141, P155-
dc.description.citedreferenceTan-Chiu E, 2005, J CLIN ONCOL, V23, P7811, DOI 10.1200/JCO.2005.02.4091-
dc.description.citedreferenceRomond EH, 2005, NEW ENGL J MED, V353, P1673-
dc.description.citedreferenceAbe O, 2005, LANCET, V365, P1687-
dc.description.citedreference*HLTH INS REG AG, 2005, REP REAL INF DEL MED-
dc.description.citedreferenceLEE JS, 2004, J BREAST CANCERER, V7, P174-
dc.description.citedreference*MIN HLTH WELF KOR, 2003, 2002 ANN REP KOR CEN-
dc.description.citedreferenceVeronesi U, 2002, NEW ENGL J MED, V347, P1227-
dc.description.citedreferenceFisher B, 2002, NEW ENGL J MED, V347, P1233-
dc.description.citedreferenceWOLMARK N, 2001, J NATL CANC I MONOGR, V30, P96-
dc.description.citedreferenceKrag D, 1998, NEW ENGL J MED, V339, P941-
dc.description.citedreferenceAbe O, 1998, LANCET, V352, P930-
dc.description.citedreferenceGO BJ, 1998, J KOREAN SURG SOC, V55, P959-
dc.description.citedreferenceVeronesi U, 1997, LANCET, V349, P1864-
dc.description.citedreferenceStyblo TM, 1996, ANN SURG ONCOL, V3, P375-
dc.description.citedreferenceMADIGAN MP, 1995, J NATL CANCER I, V87, P1681-
dc.description.citedreferenceGODFREY PM, 1995, PLAST RECONSTR SURG, V95, P1039-
dc.description.tc0-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share